Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Up 24.9% in January

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totaling 2,189 shares, a growth of 24.9% from the December 31st total of 1,752 shares. Based on an average trading volume of 1,935 shares, the days-to-cover ratio is presently 1.1 days. Based on an average trading volume of 1,935 shares, the days-to-cover ratio is presently 1.1 days.

Hikma Pharmaceuticals Stock Performance

Shares of OTCMKTS HKMPY opened at $43.43 on Wednesday. The company’s fifty day moving average is $41.94 and its two-hundred day moving average is $45.53. Hikma Pharmaceuticals has a one year low of $39.93 and a one year high of $59.26.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.